Anzeige
❌
Mehr »
Mittwoch, 25.03.2026 - Börsentäglich über 12.000 News
Drohnenkrieg eskaliert - und diese Aktie greift nach zwei Mega-Märkten
Anzeige

Indizes
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Aktien
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Xetra-Orderbuch

Fonds
Kurs
%

Devisen
Kurs
%

Rohstoffe
Kurs
%

Themen
Kurs
%

Erweiterte Suche

WKN: 157088 | ISIN: BG11SOSOBT18 | Ticker-Symbol: 3JR
Frankfurt
24.03.26 | 21:49
1,600 Euro
-2,14 % -0,035
Branche
Pharma
Aktienmarkt
OSTEUROPA
1-Jahres-Chart
SOPHARMA AD Chart 1 Jahr
5-Tage-Chart
SOPHARMA AD 5-Tage-Chart

Aktuelle News zur SOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20142x3news
MoSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/2014 1x3news
FrSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
FrSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
DoSopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20142x3news
18.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
11.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20145x3news
SOPHARMA Aktie jetzt für 0€ handeln
10.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
09.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20142x3news
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
06.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
05.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
05.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
04.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
04.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20142x3news
02.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
02.03.Sopharma AD: Inside information under art. 17, para 1, in relation with art. 7 of the Regulation (EU) No 596/20141x3news
1 2 3 4 5 Weiter >>
94 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1